Pediatric delamanid treatment for children with rifampicin-resistant TB
- PMID: 36163672
- PMCID: PMC9524514
- DOI: 10.5588/ijtld.22.0264
Pediatric delamanid treatment for children with rifampicin-resistant TB
Conflict of interest statement
References
-
- Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. Lancet. 2019;294:967–978. - PubMed
-
- Chiang SS, et al. Barriers to the diagnosis of childhood tuberculosis: a qualitative study. Int J Tuberc Lung Dis. 2015;19(10):1144–1152. - PubMed
-
- Lopez-Varela E, et al. Treatment outcomes and safety in children with rifampicin-resistant tuberculosis. Int J Tuberc Lung Dis. 2022;26(2):133–141. - PubMed
-
- Furin J, et al. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015;19(Suppl 1):55–60. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
